首頁 > 市場調查報告書 > 醫療設備

透析設備

市場調查報告書

商品編碼

1606496

日本透析設備市場 - 2024-2031

Japan Dialysis Equipment Market - 2024-2031

出版日期: 2024年12月04日 | 出版商:

DataM Intelligence | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

日本透析設備市場在2023年達到28億美元，預計2031年將達到40.6億美元，在2024-2031年預測期間複合年成長率為4.5%。

透析機是一種在血液透析過程中過濾血液、維持電解質平衡和溫度的醫療設備。透析機是一種混合和監測稱為透析液的液體的設備，透析液可去除血液中的廢物並保持電解質和礦物質的適當水平。它還可以監測體外的血流，並可能發出警報以提醒使用者進行任何必要的檢查。

市場動態：

驅動程式和限制

科技進步的崛起

日本透析設備市場受到技術進步的推動，提高了患者的治療效果和營運效率。日本的醫療技術創新帶來了即時監控、自動液體平衡以及透析設備中人工智慧和物聯網的整合。這些進步最大限度地減少了慢性腎臟病患者的併發症並提高了生活品質。

攜帶式和家用透析系統也越來越受歡迎。生物相容性透析器和高性能薄膜提高了過濾效率並減少了不良反應。日本製造商與學術機構合作，開發適合當地醫療保健需求的可靠系統。

例如，日本研究人員團隊創造了一種攜帶式透析系統，高30厘米、寬18厘米、深12厘米，包括電池重3至4公斤。該設備旨在在災難期間難以獲得醫療服務時充當救生員。該設備比傳統的攜帶式透析機小得多。

此外，遠端監控和預測分析等數位健康技術正在徹底改變透析管理，從而實現早期干預和更好的資源利用。這些技術進步使日本成為透析護理領域的領導者，建立了全球基準並推動了國內成長。

設備成本高

儘管日本擁有先進的醫療基礎設施和對腎臟護理服務的高需求，但由於設備成本高昂，日本的透析設備市場仍面臨嚴重限制。初始投資和持續的維護費用給醫療保健提供者帶來了財務挑戰，尤其是小型診所和農村設施。日本的全民健保制度和報銷政策緩解了患者的一些經濟壓力，但營運費用仍然是一個障礙。透過具有成本效益的創新、政府補貼或合作夥伴關係來解決這一限制可以確保日本透析行業更廣泛的可及性和市場成長。

例如，Nipro 透析機是醫院、診所和診斷中心使用的醫療設備，用於在腎臟無法淨化血液時過濾血液。印度的平均價格在 1223995-1500000 日圓之間，具體取決於機器類型、吞吐量、容量、高級功能、配件和型號。這些機器可以從醫院商店在線購買。

A dialysis machine is a medical device that filters blood during hemodialysis procedures, maintaining electrolyte balance and temperature. The dialysis machine is a device that mixes and monitors the fluid called dialysate, which removes waste products from the blood and maintains proper levels of electrolytes and minerals. It also monitors blood flow outside the body and may sound an alarm to alert the user of any necessary checks.

Market Dynamics: Drivers & Restraints

Rise in the Technological Advancements

The Japan dialysis equipment market is driven by technological advancements, enhancing patient outcomes and operational efficiency. Japan's medical technology innovation has led to real-time monitoring, automated fluid balancing, and integration with AI and IoT in dialysis devices. These advancements minimize complications and improve the quality of life for patients with chronic kidney disease.

Portable and home-based dialysis systems are also gaining traction. Biocompatible dialyzers and high-performance membranes have improved filtration efficiency and reduced adverse reactions. Japanese manufacturers, collaborating with academic institutions, develop reliable systems tailored to local healthcare needs.

For instance, a team of Japanese researchers have created a portable dialysis system that is 30 centimeters tall, 18 cm wide, and 12 cm deep, weighing 3 to 4 kilograms, including batteries. The device is designed to be a life-saver during disasters when medical care is difficult to access. The device is significantly smaller than conventional portable dialysis machines.

Moreover, digital health technologies like telemonitoring and predictive analytics are revolutionizing dialysis management, allowing early intervention and better resource utilization. These technological strides position Japan as a leader in dialysis care, setting global benchmarks and driving domestic growth.

High Cost of the Equipment

Japan's dialysis equipment market faces significant restraint due to the high cost of equipment, despite the country's advanced healthcare infrastructure and high demand for renal care services. Initial investments and ongoing maintenance expenses pose financial challenges for healthcare providers, especially smaller clinics and rural facilities. Japan's universal healthcare system and reimbursement policies alleviate some financial strain for patients, but operational expenses remain a barrier. Addressing this restraint through cost-effective innovations, government subsidies, or partnerships could ensure broader accessibility and market growth in Japan's dialysis sector.

For instance, A Nipro dialysis machine is a medical device used in hospitals, clinics, and diagnostic centers to filter blood when kidneys cannot purify it. The average price in India is between 1223995-1500000 Japan Yen, depending on machine type, throughput, capacity, advanced features, accessories, and models. These machines can be purchased online from hospital stores.

Segment Analysis

The Japan dialysis equipment market is segmented based on product type, disease condition and end user.

Product Type:

Hemodialysis Devices segment is expected to dominate the dialysis equipment market share

The hemodialysis devices segment holds a major portion of the dialysis equipment market share and is expected to continue to hold a significant portion of the dialysis equipment market share during the forecast period.

Japan has seen a significant growth in the end-stage renal disease hemodialysis devices market due to innovative dialyzing systems. The country has one of the highest per capita dialysis patients globally, emphasizing the importance of efficient devices for the elderly population. Hemodialysis devices help patients clean blood from harmful substances like toxins, waste, and excess water due to kidney failure.

The Japan market is characterized by high-tech machines with accuracy, reliability, and patient safety. Advancements in real-time monitoring, automatic functions, and easy navigation have driven the adoption of hemodialysis equipment. Local players understand local market demands, dominating the market, while international players bring better technologies and quality. The use of AI and IoT devices in hemodialysis machines is also increasing due to improved treatment protocols and results. Government policies and reimbursement systems also contribute to the market for hemodialysis devices in Japan.

Hospitals segment is the fastest-growing segment in the dialysis equipment market share

The hospitals segment is the fastest-growing segment in the dialysis equipment market share and is expected to hold the market share over the forecast period.

Japan's hospitals are key providers of hemodialysis services, offering comprehensive services like patient monitoring, emergency care, and individualized treatment plans. With a universal healthcare system and specialized nephrology departments, hospitals are central to delivering dialysis treatments to the growing patient population.

They provide state-of-the-art equipment, support cutting-edge technologies, and facilitate research and clinical trials. Japan's hospitals maintain rigorous standards for infection control and patient safety, ensuring the dialysis process adheres to the highest quality benchmarks. Urban hospitals house larger dialysis centers, while rural hospitals work towards expanding accessibility. Government funding and insurance coverage encourage patients to seek care from these well-equipped facilities. As chronic kidney disease burdens rise, hospitals will continue to drive the growth and evolution of the dialysis equipment market in Japan.

Competitive Landscape

The major Japan players in the dialysis equipment market include T Nikkiso Co., Ltd, Fresenius Medical Care Japan K.K, Kawasumi Laboratories, Inc, Asahi Kasei Medical Co., Ltd., Toray Medical Co., Ltd., Terumo Corporation,Nipro Corporation, JMS Co., Ltd among others.

Emerging Players

The emerging players in the dialysis equipment market include Medikit Co., Ltd, Sanritsu Corporation, Hitachi Healthcare Systems, Kyowa Hakko Kirin Co., Ltd and among others.

Key Developments

In September 2022, WEGO Terumo, a joint venture between WEGO and Terumo, has received regulatory approval from the National Medical Products Administration to manufacture and market a new neutral peritoneal dialysis solution.

Why Purchase the Report?

To visualize the Japan dialysis equipment market segmentation based on product type, disease condition, end user and understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of the dialysis equipment market with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping is available in excel consisting of key products of all the major players.

The Japan dialysis equipment market report would provide approximately 70 tables, 65 figures, and 184 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Disease Condition
3.3. Snippet by End User

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rise in the Technological Advancements
4.2. Restraints
4.3. Opportunity
- 4.3.1. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Hemodialysis Devices*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Peritoneal Dialysis Devices
6.4. Others

7. By Disease Condition

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Condition
- 7.1.2. Market Attractiveness Index, By Disease Condition
7.2. Chronic*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Acute

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Clinics
8.4. Dialysis Centers
8.5. Ambulatory Surgical Centers
8.6. Homecare Settings

9. Competitive Landscape

9.1. Competitive Scenario
9.2. Market Positioning/Share Analysis
9.3. Mergers and Acquisitions Analysis

10. Company Profiles

10.1. Nikkiso Co., Ltd.*
- 10.1.1. Company Overview
- 10.1.2. Product Portfolio and Description
- 10.1.3. Financial Overview
- 10.1.4. Key Developments
10.2. Fresenius Medical Care Japan K.K.
10.3. Kawasumi Laboratories, Inc.
10.4. Asahi Kasei Medical Co., Ltd.
10.5. Toray Medical Co., Ltd.
10.6. Terumo Corporation
10.7. Nipro Corporation
10.8. JMS Co., Ltd.

LIST NOT EXHAUSTIVE